IM Cannabis (IMCC) Change in Accured Expenses (2019 - 2026)

IM Cannabis' Change in Accured Expenses history runs 8 years deep, the most recent figure standing at -$1.4 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 135.09% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at -$6.1 million (down 867.35% YoY), while the FY2024 annual figure was -$5.2 million, down 839.09% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$1.4 million, up from -$1.8 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $11.4 million in Q4 2022, with the low at -$6.8 million in Q4 2024.
• The 5-year median for Change in Accured Expenses is -$345000.8 (2022), against an average of $260141.6.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses sank 19571.21% in 2024, then surged 289.67% in 2025.
• IM Cannabis' Change in Accured Expenses stood at $11.4 million in 2022, then tumbled by 106.55% to -$745553.6 in 2023, then plunged by 818.58% to -$6.8 million in 2024, then jumped by 73.98% to -$1.8 million in 2025, then grew by 23.92% to -$1.4 million in 2026.
• Business Quant data shows IMCC's Change in Accured Expenses at -$1.4 million in Q1 2026, -$1.8 million in Q2 2025, and $3.9 million in Q1 2025.